Exploring the role and therapeutic potential of lipid metabolism in acute kidney injury
- PMID: 39319697
- PMCID: PMC11425701
- DOI: 10.1080/0886022X.2024.2403652
Exploring the role and therapeutic potential of lipid metabolism in acute kidney injury
Abstract
Acute kidney injury (AKI) is a prevalent condition, yet no specific treatment is available. Extensive research has revealed the pivotal role of lipid-related alterations in AKI. Lipid metabolism plays an essential role in the sustenance of the kidneys. In addition to their energy-supplying function, lipids contribute to the formation of renal biomembranes and the establishment of the renal microenvironment. Moreover, lipids or their metabolites actively participate in signal transduction, which governs various vital biological processes, such as proliferation, differentiation, apoptosis, autophagy, and epithelial-mesenchymal transition. While previous studies have focused predominantly on abnormalities in lipid metabolism in chronic kidney disease, this review focuses on lipid metabolism anomalies in AKI. We explore the significance of lipid metabolism products as potential biomarkers for the early diagnosis and classification of AKI. Additionally, this review assesses current preclinical investigations on the modulation of lipid metabolism in the progression of AKI. Finally, on the basis of existing research, this review proposes future directions, highlights challenges, and presents novel targets and innovative ideas for the treatment of and intervention in AKI.
Keywords: Acute kidney injury; FAO; clinical translation; lipid; metabolism.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Similar articles
-
Relieving lipid accumulation through UCP1 suppresses the progression of acute kidney injury by promoting the AMPK/ULK1/autophagy pathway.Theranostics. 2021 Mar 4;11(10):4637-4654. doi: 10.7150/thno.56082. eCollection 2021. Theranostics. 2021. PMID: 33754018 Free PMC article.
-
Sirt3 modulates fatty acid oxidation and attenuates cisplatin-induced AKI in mice.J Cell Mol Med. 2020 May;24(9):5109-5121. doi: 10.1111/jcmm.15148. Epub 2020 Apr 12. J Cell Mol Med. 2020. PMID: 32281286 Free PMC article.
-
Acute kidney injury and energy metabolism.Clin Chim Acta. 2025 Mar 15;570:120208. doi: 10.1016/j.cca.2025.120208. Epub 2025 Feb 20. Clin Chim Acta. 2025. PMID: 39986590 Review.
-
Spatial Metabolomics in Acute Kidney Injury.Semin Nephrol. 2024 Nov;44(6):151580. doi: 10.1016/j.semnephrol.2025.151580. Epub 2025 Apr 12. Semin Nephrol. 2024. PMID: 40221281 Review.
-
Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.Stem Cell Res Ther. 2021 Jun 28;12(1):367. doi: 10.1186/s13287-021-02374-x. Stem Cell Res Ther. 2021. PMID: 34183058 Free PMC article.
Cited by
-
Metabolomics- and proteomics-based multi-omics integration reveals early metabolite alterations in sepsis-associated acute kidney injury.BMC Med. 2025 Feb 11;23(1):79. doi: 10.1186/s12916-025-03920-7. BMC Med. 2025. PMID: 39934788 Free PMC article.
-
Association between triglyceride glucose body mass index and 1 year all cause mortality in stage 4 CKM syndrome patients.Sci Rep. 2025 May 16;15(1):17019. doi: 10.1038/s41598-025-01549-3. Sci Rep. 2025. PMID: 40379745 Free PMC article.
-
March6 Protects Against Acute Kidney Injury by Suppressing Renal Tubular Epithelial Cell Ferroptosis Through the Destabilization of P53 and ACSL4 Proteins.Inflammation. 2025 May 30. doi: 10.1007/s10753-025-02319-z. Online ahead of print. Inflammation. 2025. PMID: 40445517
-
The role of ferroptosis in acute kidney injury: the preemptive mode of cell death and the bridging effect.Ren Fail. 2025 Dec;47(1):2536732. doi: 10.1080/0886022X.2025.2536732. Epub 2025 Aug 29. Ren Fail. 2025. PMID: 40878481 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources